The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...

AI is already at work in the world’s airports. In the future, airports may use robots for tasks currently done by humans.

In a wooden shack on stilts overlooking a muddy tributary of the Amazon, the shaman gently lays his palm on the head of his ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

How cyber, ISR and electronic warfare technologies enabled Operation Absolute Resolve and the Venezuelan president's capture, ...

Rather than focusing on counter-terrorism operations, dialogue should be supported as a way to tackle local dynamics ...

Veterans often step into ownership already equipped with the leadership toolkit many entrepreneurs spend years developing.

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...